Else Nutrition Holdings Inc. Q3 2025 Earnings Recap

Else Nutrition delivered a promising financial turnaround in Q3 2025, substantially improving gross margins and reducing operational expenses, while positioning itself for future growth amid temporary revenue challenges.

Key Takeaways

• Gross margin surged to 34%, a significant recovery from negative margins a year ago, driven by structural improvements in manufacturing and cost management.
• Operational expenses decreased by 68% year-over-year to $1.15 million, enhancing financial agility and sustainability.
• Monthly cash burn fell below $200,000, signaling improved operational efficiency and a path toward cash flow breakeven expected by late 2026 to early 2027.
• Revenue slightly declined to $1.66 million due to temporary supply issues; however, strong demand for products remains intact.
• The company is advancing plans for its plant-based infant formula, with increasing interest from potential international partners for commercial collaborations.